首页> 美国卫生研究院文献>Cancer Management and Research >Isolated limb infusion chemotherapy for melanoma: an overview of early experience at the Adelaide Melanoma Unit
【2h】

Isolated limb infusion chemotherapy for melanoma: an overview of early experience at the Adelaide Melanoma Unit

机译:孤立性肢体灌注化疗治疗黑色素瘤:阿德莱德黑色素瘤部门的早期经验概述

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundIsolated limb infusion (ILI) using cytotoxic agents has been demonstrated to be an effective and less invasive alternative modality than isolated limb perfusion for the treatment of melanoma localized to a limb. Percutaneous catheters were inserted into the axial artery and vein of the affected limb while using a pneumatic cuff to restrict limb vascular flow proximally to “isolate” the limb from the body and enable delivery of high-dose intra-arterial chemotherapy selectively to the limb. The ILI technique was developed at the Sydney Melanoma Unit (now renamed the Melanoma Institute Australia), and only a few other centers have reported separate results. We report our early results using the ILI technique for management of locally recurrent surgically nonresectable melanoma.
机译:背景技术已证明,与单独的肢体灌注相比,使用细胞毒剂进行的肢体灌注(ILI)是一种有效且侵入性更小的替代方法,可用于治疗定位于肢体的黑色素瘤。将经皮导管插入患肢的轴向动脉和静脉中,同时使用气动袖带限制近端肢体血管流动,以将“肢体”与身体“隔离”,并能将大剂量动脉内化疗选择性地输送到肢体。 ILI技术是由悉尼黑色素瘤部门(现已更名为澳大利亚黑色素瘤研究所)开发的,只有其他几个中心报告了单独的结果。我们报告了我们的早期结果,使用ILI技术治疗局部复发性不可手术切除的黑色素瘤。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号